Enabling a robust scalable manufacturing process for therapeutic exosomes through oncogenic immortalization of human ESC-derived MSCs

BACKGROUND: Exosomes or secreted bi-lipid vesicles from human ESC-derived mesenchymal stem cells (hESC-MSCs) have been shown to reduce myocardial ischemia/reperfusion injury in animal models. However, as hESC-MSCs are not infinitely expansible, large scale production of these exosomes would require...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tian Sheng, Arslan, Fatih, Yin, Yijun, Tan, Soon Sim, Lai, Ruenn Chai, Choo, Andre Boon Hwa, Padmanabhan, Jayanthi, Lee, Chuen Neng, de Kleijn, Dominique PV, Lim, Sai Kiang
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100248/
https://www.ncbi.nlm.nih.gov/pubmed/21513579
http://dx.doi.org/10.1186/1479-5876-9-47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100248/
https://www.ncbi.nlm.nih.gov/pubmed/21513579
http://dx.doi.org/10.1186/1479-5876-9-47

Ejemplares similares